{
     "PMID": "25288301",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20150202",
     "LR": "20141202",
     "IS": "1872-8421 (Electronic) 0165-5728 (Linking)",
     "VI": "276",
     "IP": "1-2",
     "DP": "2014 Nov 15",
     "TI": "Effects of ouabain on cytokine/chemokine levels in an animal model of mania.",
     "PG": "236-9",
     "LID": "10.1016/j.jneuroim.2014.09.007 [doi] S0165-5728(14)00884-4 [pii]",
     "AB": "Bipolar disorder (BD) is a chronic and severe psychiatric disorder and despite its importance, little is known about the precise pathophysiology of this disorder. Several studies have reported that inflammation plays a role in the pathogenesis of BD and that cytokines are altered in these patients. Intracerebroventricular (ICV) injection of ouabain (a potent Na(+)/K(+)-ATPase inhibitor) in rats resulted in manic-like effects and it has been widely used as an animal model of bipolar mania. In this study, we assessed the cytokine levels (IL-1beta, IL-6, IL-10, TNF-alpha, CINC-1) in the brain structures (hippocampus, striatum, frontal cortex, amygdala), serum and cerebrospinal fluid (CSF) of rats submitted to an animal model of mania induced by ouabain. Our findings demonstrated that ouabain induced hyperlocomotion in rats. However, the only cytokine that showed alteration was IL-6, which was decreased in the striatum after ouabain administration. In conclusion, despite the ouabain administration in rats be a valid model to study the physiopathology of bipolar mania, it seems that this model was not able to mimic the changes in cytokines observed in bipolar patients.",
     "CI": [
          "Copyright (c) 2014 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Tonin, Paula T",
          "Valvassori, Samira S",
          "Lopes-Borges, Jessica",
          "Mariot, Edemilson",
          "Varela, Roger B",
          "Teixeira, Antonio Lucio",
          "Quevedo, Joao"
     ],
     "AU": [
          "Tonin PT",
          "Valvassori SS",
          "Lopes-Borges J",
          "Mariot E",
          "Varela RB",
          "Teixeira AL",
          "Quevedo J"
     ],
     "AD": "Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude (PPGCS), Unidade Academica de Ciencias da Saude (UNASAU), Universidade do Extremo Sul Catarinense (UNESC), Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude (PPGCS), Unidade Academica de Ciencias da Saude (UNASAU), Universidade do Extremo Sul Catarinense (UNESC), Criciuma, SC, Brazil. Electronic address: samiravalvassori@unesc.net. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude (PPGCS), Unidade Academica de Ciencias da Saude (UNASAU), Universidade do Extremo Sul Catarinense (UNESC), Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude (PPGCS), Unidade Academica de Ciencias da Saude (UNASAU), Universidade do Extremo Sul Catarinense (UNESC), Criciuma, SC, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude (PPGCS), Unidade Academica de Ciencias da Saude (UNASAU), Universidade do Extremo Sul Catarinense (UNESC), Criciuma, SC, Brazil. Laboratorio de Imunofarmacologia, Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude (PPGCS), Unidade Academica de Ciencias da Saude (UNASAU), Universidade do Extremo Sul Catarinense (UNESC), Criciuma, SC, Brazil; Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, Houston, TX, USA.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20140917",
     "PL": "Netherlands",
     "TA": "J Neuroimmunol",
     "JT": "Journal of neuroimmunology",
     "JID": "8109498",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (Cytokines)",
          "5ACL011P69 (Ouabain)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antidepressive Agents/pharmacology/*therapeutic use",
          "Bipolar Disorder/*drug therapy/*metabolism",
          "Brain/drug effects/metabolism/pathology",
          "Cytokines/*metabolism",
          "Disease Models, Animal",
          "Exploratory Behavior/drug effects",
          "Injections, Intraventricular",
          "Male",
          "Ouabain/pharmacology/*therapeutic use",
          "Rats"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Animal model of mania",
          "Bipolar disorder",
          "Cytokines",
          "Ouabain"
     ],
     "EDAT": "2014/10/08 06:00",
     "MHDA": "2015/02/03 06:00",
     "CRDT": [
          "2014/10/08 06:00"
     ],
     "PHST": [
          "2014/08/24 00:00 [received]",
          "2014/09/07 00:00 [revised]",
          "2014/09/10 00:00 [accepted]",
          "2014/10/08 06:00 [entrez]",
          "2014/10/08 06:00 [pubmed]",
          "2015/02/03 06:00 [medline]"
     ],
     "AID": [
          "S0165-5728(14)00884-4 [pii]",
          "10.1016/j.jneuroim.2014.09.007 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Neuroimmunol. 2014 Nov 15;276(1-2):236-9. doi: 10.1016/j.jneuroim.2014.09.007. Epub 2014 Sep 17.",
     "term": "hippocampus"
}